Search - Supreme Court of the United States

Home > Search Results

Docket for 19A886

No. 19A886

Title:	Sanofi-Aventis Deutschland GmbH, Applicant v. Mylan Pharmaceuticals Inc.
Docketed:	February 7, 2020
Lower Ct:	United States Court of Appeals for the Federal Circuit
Case Numbers:	(2019-1368 2019-1369)

Proceedings and Orders

Feb 07 2020

Application (19A886) for a stay, submitted to The Chief Justice.
Main Document Proof of Service

Feb 10 2020

UPON CONSIDERATION of the application of counsel for the applicant, IT IS ORDERED that the mandate of the United States Court of Appeals for the Federal Circuit, case Nos. 2019-1368 and 2019-1369, is hereby stayed pending receipt of a response, due on or before Thursday, February 13, 2020, by 4:30 p.m. ET, and further order of the undersigned or of the Court.

Feb 13 2020

Response to application from respondent Mylan Pharmaceuticals Inc. filed.
Main Document Proof of Service

Feb 14 2020

The order heretofore issued by The Chief Justice on February 10, 2020, is vacated. The application for a stay is, in all respects, denied.

Feb 14 2020

Reply of applicant Sanofi-Aventis Deutschland GmbH filed.
Reply

Attorneys

Attorneys for Petitioners

Adam Baker Banks
Counsel of Record

Weil, Gotshal & Manges LLP
767 Fifth Avenue
New York, NY 10153
adam.banks@weil.com
Ph: 212 310-8000
Party name: Sanofi-Aventis Deutschland GmbH

Attorneys for Respondents

Douglas H Carsten
Counsel of Record

Wilson Sonsini Goodrich & Rosati
12235 El Camino Real
San Diego, CA 92130
dcarsten@wsgr.com
Ph: 8583502305
Party name: Mylan Pharmaceuticals Inc.

Opinions

Filing & Rules

Oral Arguments

Case Documents

News Media

About

Visit

SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543